MedTrace Logo

Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)

NCT06122961 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18198

Last updated 2025-05-09

No results posted yet for this study

Summary

This study will collect medical and background information from participants with diseases that affect the heart and blood vessels (cardiovascular disease). Participants will continue their normal care and will not get any treatment other than those the study doctor has prescribed.

Conditions

Interventions

OTHER

No treatment given

No treatment given

Sponsors & Collaborators

Principal Investigators

  • Clinical Transparency (dept. 2834) · Novo Nordisk A/S

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-23
Primary Completion
2025-04-30
Completion
2025-04-30

Countries

  • United States
  • Argentina
  • Australia
  • Brazil
  • Canada
  • China
  • Czechia
  • Denmark
  • France
  • Germany
  • India
  • Italy
  • Norway
  • Poland
  • South Korea
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06122961 on ClinicalTrials.gov